OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
July 15, 2024
The acquisition provides Lantheus with worldwide exclusive rights to ß amyloid PET imaging agent, NAV-4694, for its Alzheimer’s disease diagnostic and treatment portfolio.
PRAC is recommending that patients who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) consider the risk of delayed gastric emptying before undergoing surgery with general anesthesia or deep sedation.
July 04, 2024
The companies have restructured their existing collaboration into a licensing agreement that invests in mRNA development.
July 01, 2024
EMA’s CHMP gave positive opinions on a nasal delivery for epinephrine and for a first-in-class medicine to treat pulmonary arterial hypertension, among others, including a biosimilar for treatment of autoimmune diseases.
June 29, 2024
The seven chosen sponsors will help accelerate development of novel drugs and biologics for rare diseases.
June 26, 2024
Yoni Tyberg, associate director of the Special Program Staff in the Office of New Drugs, provided an update on efforts to modernize CDER processes.